Maoz, Asaf
Weiskopf, Kipp
Article History
First Online: 7 September 2023
Competing interests
: A.M. and K.W. have filed US patent applications related to macrophage-based cancer therapies via the Whitehead Institute. K.W. holds relevant patents and royalties (via Stanford University, the Whitehead Institute and Gilead Sciences), is a co-founder, scientific advisory board member and equity holder of ALX Oncology, DEM Biopharma and Solu Therapeutics, has been a scientific advisor of Carisma Therapeutics and owns stock of Ginkgo Bioworks.